Skin and Connective Tissue Diseases: News and Research on Pemphigoid, Bullous

FDA approves Dupixent for bullous pemphigoid

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.